Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...

Despite data suggesting that more than half of the patients (53.6%) discontinued GLP-1 drugs within a year, and 72.2% within 2 years, guidance on how to appropriately wean patients off the drugs, or ...

XREAL is wrapping up 2025 with the launch of a new entry-level AR glasses model, the XREAL 1S. It sits below the more expensive XREAL One Pro (announced in July) in the lineup and is the first in the ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

The Toronto Blue Jays made one of the boldest moves of the 2025 MLB offseason so far by locking up ace Dylan Cease on a seven-year, $210 million contract. The deal instantly strengthens the Blue Jays ...

GLP-1 agonists have taken the pharmaceutical world by storm. The active ingredient, semaglutide, is used in the now-famous Ozempic and Wegovy medications for diabetes and weight loss. Already, these ...

CHICAGO, Nov 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and ...

It’s been a long trip but the newest suburban Brick & Mortar co-working space is open in a prime spot across from Cook Park in downtown Libertyville. Built as A&P Grocery store, the single-story ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Novo Nordisk’s new CEO dismissed on Wednesday that his company’s ...

Don’t think twice, it’s all right. Bob Dylan’s earliest New York recordings are finally getting their due. “The Bootleg Series Vol. 18: Through the Open Window, 1956‑1963,” a massive collection of ...

The obesity rate in the U.S. is continuing its downward trend. The news comes three years after obesity rates hit a record high. In 2022, almost four out of 10 (39.9%) of Americans met the threshold ...